Clarivate (NYSE:CLVT) Issues FY25 Earnings Guidance

Clarivate (NYSE:CLVT) updated its FY25 earnings guidance on Wednesday. The company provided EPS guidance of $0.60-$0.70 for the period, compared to the consensus EPS estimate of $0.73. The company issued revenue guidance of $2.28-$2.40 billion, compared to the consensus revenue estimate of $2.53 billion. Clarivate also updated its FY 2025 guidance to 0.600-0.700 EPS.

Analysts Set New Price Targets

A number of equities research analysts recently weighed in on the stock. Royal Bank of Canada lowered their target price on shares of Clarivate from $7.00 to $6.00 and set a “sector perform” rating on the stock in a research note on Thursday, November 7th. Barclays decreased their price target on shares of Clarivate from $5.00 to $4.00 and set an “underweight” rating on the stock in a research note on Thursday, November 7th. Finally, William Blair downgraded shares of Clarivate from an “outperform” rating to a “market perform” rating in a research note on Wednesday, November 6th. One equities research analyst has rated the stock with a sell rating, three have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $7.10.

Clarivate Trading Down 1.6 %

Shares of Clarivate stock traded down $0.08 on Wednesday, hitting $4.76. The stock had a trading volume of 20,477,251 shares, compared to its average volume of 5,035,243. The company has a quick ratio of 0.88, a current ratio of 0.88 and a debt-to-equity ratio of 0.84. Clarivate has a one year low of $4.22 and a one year high of $9.07. The stock has a market cap of $3.38 billion, a price-to-earnings ratio of -2.39 and a beta of 1.17. The stock’s 50-day simple moving average is $5.15 and its two-hundred day simple moving average is $5.82.

Clarivate declared that its Board of Directors has initiated a stock repurchase program on Monday, December 16th that permits the company to repurchase $500.00 million in outstanding shares. This repurchase authorization permits the company to reacquire up to 12.8% of its stock through open market purchases. Stock repurchase programs are typically a sign that the company’s board believes its shares are undervalued.

Insider Transactions at Clarivate

In other news, Director Michael J. Angelakis bought 765,000 shares of the business’s stock in a transaction dated Friday, November 22nd. The shares were purchased at an average price of $5.19 per share, for a total transaction of $3,970,350.00. Following the completion of the acquisition, the director now owns 3,465,000 shares of the company’s stock, valued at approximately $17,983,350. This trade represents a 28.33 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Company insiders own 23.14% of the company’s stock.

Clarivate Company Profile

Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications.